Mineral Bone Disorder in Dialysis
MBDialysis
Mineral and Bone Disorder in Chronic Kidney Disease: A Comparative Analysis of Hemodialysis and Peritoneal Dialysis Modalities
1 other identifier
observational
167
1 country
1
Brief Summary
This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673). Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2020
CompletedFirst Submitted
Initial submission to the registry
October 2, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedOctober 8, 2025
May 1, 2022
7 months
October 2, 2025
October 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Blood values
Serum levels of calcium, phosphorus, parathyroid hormone, albumin, hemoglobin, BUN, creatinine, and dialysate calcium
At the enrollment
Study Arms (1)
dialysis
167 patients diagnosed with CKD and undergoing HD or PD were included in the study
Interventions
Eligibility Criteria
This study was performed with dialysis patients from Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
You may qualify if:
- Age ≥ 18 years,
- Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis)
- Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium
- Patient consent to participate
You may not qualify if:
- Age \< 18 years
- Patients not on dialysis treatment
- Missing or incomplete laboratory data
- History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism
- Patients who did not provide consent or could not complete the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
Kayseri, Turkey (Türkiye)
Biospecimen
blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
October 2, 2025
First Posted
October 8, 2025
Study Start
September 25, 2019
Primary Completion
April 15, 2020
Study Completion
June 20, 2020
Last Updated
October 8, 2025
Record last verified: 2022-05